Product image of Gudivin (Posaconazole) supplied by GNH India

Gudivin

Active Ingredient:
Posaconazole
Origin:
EU

Gudivin (Posaconazole)

Gudivin is an oral antifungal medication that contains the active ingredient posaconazole. It is supplied in tablet or suspension form (strength not specified) and marketed in the EU as a prescription product. Posaconazole belongs to the triazole class of antifungal agents and works by inhibiting fungal lanosterol 14α‑demethylase, disrupting ergosterol synthesis and cell‑membrane formation. It is prescribed for treatment and prevention of invasive fungal infections in immunocompromised patients.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gudivin (posaconazole) is indicated for several serious fungal conditions, primarily in patients with weakened immune systems.

  • Treatment of invasive aspergillosis
  • Treatment of invasive candidiasis
  • Prophylaxis of fungal infections in immunocompromised patients
  • Management of rare or refractory fungal infections
  • Prevention of fungal disease in hematopoietic stem cell transplantation recipients

Side Effects

The safety profile of Gudivin includes a range of adverse effects that vary in frequency and severity.

Common

  • Nausea or vomiting
  • Diarrhea or abdominal discomfort
  • Headache
  • Elevated liver enzymes
  • Mild rash

Serious

  • Severe liver injury or hepatitis
  • QT interval prolongation leading to cardiac arrhythmias
  • Severe allergic reactions, including Stevens‑Johnson syndrome
  • Visual disturbances such as blurred vision
  • Adrenal insufficiency or hormonal disturbances

Precautions & Warnings

Before initiating Gudivin, clinicians should evaluate several precautionary factors to minimize risk.

  • Assess baseline liver function and monitor periodically during therapy
  • Monitor cardiac rhythm, especially QT interval, in patients with cardiac risk factors
  • Avoid use in individuals with known hypersensitivity to azole antifungals
  • Use caution in patients with gastrointestinal disorders that may affect drug absorption
  • Review concomitant medications for potential CYP3A4 interactions
  • Consider dose adjustment or close monitoring in renal impairment if the formulation requires
  • Counsel pregnant or breastfeeding women about the lack of established safety data

Avoid Interactions

Gudivin can interact with other medicines through metabolic pathways and transporter systems.

Avoid

  • Strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin
  • Other QT‑prolonging agents (e.g., quinidine, sotalol)
  • Antacids containing aluminum or magnesium when using the oral suspension

Use with caution

  • Statins metabolized by CYP3A4 (simvastatin, lovastatin)
  • Immunosuppressants like cyclosporine and tacrolimus
  • Oral contraceptives
  • Warfarin and other anticoagulants
  • HIV protease inhibitors

Frequently Asked Questions

Gudivin is a prescription‑only oral antifungal medication that contains the active ingredient posaconazole, a triazole class drug.

Posaconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which blocks the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to cell death.

Gudivin is commonly prescribed for invasive aspergillosis, invasive candidiasis, and for prophylaxis of fungal infections in patients with weakened immune systems, such as those undergoing chemotherapy or stem‑cell transplantation.

The safety and efficacy of Gudivin in pediatric patients have not been fully established; use in children should be based on a clinician’s judgment and available pediatric dosing guidelines.

The most frequently reported side effects include nausea, vomiting, diarrhea, abdominal pain, headache, and mild elevations in liver enzymes.

Serious reactions can include severe liver injury, QT‑interval prolongation, severe allergic skin reactions such as Stevens‑Johnson syndrome, visual disturbances, and hormonal imbalances like adrenal insufficiency.

Yes, clinicians typically monitor liver function tests, electrolytes, and cardiac rhythm (QT interval) periodically during treatment with Gudivin.

There are no specific dietary restrictions, but patients should avoid taking antacids containing aluminum or magnesium at the same time as the oral suspension, as they may reduce absorption.

Co‑administration with other azole antifungals is generally avoided because of additive effects on CYP3A4 and increased risk of toxicity.

The safety of Gudivin in pregnancy has not been established; it should be used only if the potential benefit justifies the potential risk to the fetus.

Store Gudivin at room temperature, away from moisture and heat. Keep the container tightly closed and out of reach of children.

If a dose is missed, take it as soon as you remember unless it is close to the time of the next scheduled dose. Do not double‑dose; follow the prescribing clinician’s instructions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Posaconazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT